ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,151.80
-0.38%
Dow Jones
40,211.72
0.00%
Gold vs US Dollar
2,437.57
0.63%
Brent Oil
82.885
-1.73%
Bitcoin
63,925.29
-1.43%
Pepperstone
Advertisement
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Enzymotec Ltd. - Ordinary Shares (delisted) (ENZY)

  7. Enzymotec Ltd. - Ordinary Shares (delisted) (ENZY) News

ENZYMOTEC LTD. (ENZY)

Enzymotec Ltd. - Ordinary Shares (delisted)
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ENZY
DateTimeSourceHeadlineSymbolCompany
11/05/201611:14GlobeNewswireEnzymatica's new rights issue completed - will be provided with SEK 60 millionNASDAQ:ENZYEnzymotec Ltd. - Ordinary Shares (delisted)
05/05/201613:30GlobeNewswire Inc.Enzymotec to Report First Quarter 2016 Financial ResultsNASDAQ:ENZYEnzymotec Ltd. - Ordinary Shares (delisted)
04/05/201614:00GlobeNewswire Inc.New Survey Shows Nearly 3 Out of 4 Children Treated for ADHD Have Taken a “Drug Holiday”NASDAQ:ENZYEnzymotec Ltd. - Ordinary Shares (delisted)
03/05/201609:08GlobeNewswireEnzymatica insiders plan to subscribe for SEK 16 million in new issueNASDAQ:ENZYEnzymotec Ltd. - Ordinary Shares (delisted)
28/04/201616:46GlobeNewswire Inc.New Retrospective Study Shows PS-Omega-3 Medical Food Effective in Managing ADHDNASDAQ:ENZYEnzymotec Ltd. - Ordinary Shares (delisted)
26/04/201615:30GlobeNewswireNotice of annual general meeting in Enzymatica AB (publ)NASDAQ:ENZYEnzymotec Ltd. - Ordinary Shares (delisted)
20/04/201613:54GlobeNewswireEnzymatica publishes prospectusNASDAQ:ENZYEnzymotec Ltd. - Ordinary Shares (delisted)
20/04/201610:53GlobeNewswireEnzymatica - publication of the annual report 2015NASDAQ:ENZYEnzymotec Ltd. - Ordinary Shares (delisted)
18/04/201610:00GlobeNewswireInterim Report for Enzymatica AB (publ) January-March 2016NASDAQ:ENZYEnzymotec Ltd. - Ordinary Shares (delisted)
14/04/201613:27GlobeNewswireBulletin from the extraordinary shareholders' meeting in EnzymaticaNASDAQ:ENZYEnzymotec Ltd. - Ordinary Shares (delisted)
01/04/201614:34GlobeNewswireEnzymatica completes acquisition of Zymetech and includes new board members and representative to the nomination committeeNASDAQ:ENZYEnzymotec Ltd. - Ordinary Shares (delisted)
29/03/201613:30GlobeNewswire Inc.Enzymotec Ltd. Granted Patents in U.S. for Compositions and Processes Related to Infant Nutrition and China for INFAT® Uses ...NASDAQ:ENZYEnzymotec Ltd. - Ordinary Shares (delisted)
24/03/201607:30GlobeNewswireActing CFO of Enzymatica appointedNASDAQ:ENZYEnzymotec Ltd. - Ordinary Shares (delisted)
17/03/201610:14GlobeNewswireEnzymatica AB: Updated time plan for the acquisition of Zymetech and the rights issueNASDAQ:ENZYEnzymotec Ltd. - Ordinary Shares (delisted)
16/03/201612:30GlobeNewswire Inc.InCog™, Enzymotec's Innovative Lipid Composition for Cognitive Functioning, Enhances Brain Development and Improves Surviva...NASDAQ:ENZYEnzymotec Ltd. - Ordinary Shares (delisted)
15/03/201613:42GlobeNewswireEnzymatica announces new dates for its financial informationNASDAQ:ENZYEnzymotec Ltd. - Ordinary Shares (delisted)
15/03/201611:00Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:ENZYEnzymotec Ltd. - Ordinary Shares (delisted)
15/03/201607:29GlobeNewswireNOTICE OF EXTRAORDINARY SHAREHOLDERS MEETING IN ENZYMATICA AB (PUBL)NASDAQ:ENZYEnzymotec Ltd. - Ordinary Shares (delisted)
15/03/201607:27GlobeNewswireThe board of directors in Enzymatica has resolved on a rights issue of SEK 60 millionNASDAQ:ENZYEnzymotec Ltd. - Ordinary Shares (delisted)
10/03/201600:46GlobeNewswire Inc.Enzymotec Files Annual Report on Form 20-F for the Year Ended December 31, 2015NASDAQ:ENZYEnzymotec Ltd. - Ordinary Shares (delisted)
17/02/201615:36Edgar (US Regulatory)Amended Report of Foreign Issuer (6-k/a)NASDAQ:ENZYEnzymotec Ltd. - Ordinary Shares (delisted)
17/02/201614:08GlobeNewswire Inc.CORRECTING and REPLACING -- Enzymotec Ltd. Reports Fourth Quarter and Full Year 2015 ResultsNASDAQ:ENZYEnzymotec Ltd. - Ordinary Shares (delisted)
17/02/201612:47Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:ENZYEnzymotec Ltd. - Ordinary Shares (delisted)
17/02/201612:30GlobeNewswire Inc.Enzymotec Ltd. Reports Fourth Quarter and Full Year 2015 ResultsNASDAQ:ENZYEnzymotec Ltd. - Ordinary Shares (delisted)
16/02/201611:17GlobeNewswireEnzymatica AB: Strong growth in 2015 and acquisition for international expansionNASDAQ:ENZYEnzymotec Ltd. - Ordinary Shares (delisted)
15/02/201614:10GlobeNewswireBulletin from the extraordinary shareholders' meeting in EnzymaticaNASDAQ:ENZYEnzymotec Ltd. - Ordinary Shares (delisted)
12/02/201621:10Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ENZYEnzymotec Ltd. - Ordinary Shares (delisted)
09/02/201611:09Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ENZYEnzymotec Ltd. - Ordinary Shares (delisted)
03/02/201613:30GlobeNewswire Inc.Enzymotec to Report Fourth Quarter and Full Year 2015 Financial ResultsNASDAQ:ENZYEnzymotec Ltd. - Ordinary Shares (delisted)
03/02/201610:07GlobeNewswireEnzymatica moves forward its year-end report for 2015NASDAQ:ENZYEnzymotec Ltd. - Ordinary Shares (delisted)
 Showing the most relevant articles for your search:NASDAQ:ENZY

Your Recent History

LSE
GDR
Genedrive
LSE
CPX
Cap-xx
LSE
PRU
Prudential
LSE
ITM
Itm Power
LSE
OCDO
Ocado
LSE
POS
Plexus
LSE
AAZ
Anglo Asian Mining
LSE
VAST
Vast Resources
LSE
SBTX
Skinbiotherapeutics
LSE
GWMO
Great Western Mining
LSE
LLOY
Lloyds Banking
LSE
ENET
Ethernity Networks
LSE
SYME
Supply@me Capital
LSE
GOLD
LSE
SCLP
Scancell
LSE
GKP
Gulf Keystone Petroleum
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved